HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Kin Global’s IPO – Singapore’s Top Sports Firm Is Going Public

The Quiet Powerhouse Behind Singapore’s Global Sporting Revolution If you have ever stood in the...
SGX-LISTED COMPANIES

Is Pan-United’s Stock Rally Over?

Why Pan-United’s 40% Rally Signals a Change in the Investment Guard How does a "boring"...
SGX-LISTED COMPANIES

Why Halcyon Agri’s Losses Tripled In FY2025

4 Surprising Truths from Halcyon Agri’s FY2025 Halcyon Agri’s 2025 financial report presents a brutal...
SGX-LISTED COMPANIES

Why AvePoint Is The Silent Architect Of The AI Revolution

Data Integrity is the Unseen Engine of the AI Revolution As global enterprises race to...
SGX-LISTED COMPANIES

Lum Chang Creations Continues To Grow Ahead Of Its Mainboard Upgrade

5 Surprising Takeaways from Lum Chang Creations’ Record Growth In the high-stakes architectural tapestry of...
SGX-LISTED COMPANIES

Miyoshi Sells Assets To Repay Debt In HY2026

The Paradox of Modern Business Success In the traditional world of business, success is often...
SGX-LISTED COMPANIES

The Reason The US Department Of War Awarded iX Biopharma A $41M Contract For A Painkiller

Beyond the Needle and the Pill The opioid epidemic remains one of the most significant...
SGX-LISTED COMPANIES

How Vietnam Is Negatively Impacting Hyphens Pharma’s Growth

The Southeast Asian Pharmaceutical Puzzle Navigating the healthcare landscape in Southeast Asia is often described...
SGX-LISTED COMPANIES

How Marco Polo Marine Plans To Capitalize On The Future Of Energy

A World Searching for Stability As of April 2026, the global energy landscape is defined...
SGX-LISTED COMPANIES

Why Falling Housing & Development Board Prices Might Actually Be Good For Singapore Property

The Resilience of the Home Buyer The global landscape in the first quarter of 2026...
SGX-LISTED COMPANIES

How A Pawnshop Became A High-Tech Financial Powerhouse

The Hidden Giant on the Corner For many, the image of a pawnshop is a...
SGX-LISTED COMPANIES

Oiltek Secures $350M Contract To Build Sustainable Aviation Fuel Plant In Sabah

Oiltek is Growing Five Times Faster The global aviation industry is currently navigating a high-stakes...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...